Published in Trop Med Int Health on September 01, 1998
Human African trypanosomiasis: pharmacological re-engagement with a neglected disease. Br J Pharmacol (2007) 2.96
Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects. Trends Parasitol (2014) 1.20
Activity of megazol, a trypanocidal nitroimidazole, is associated with DNA damage. Antimicrob Agents Chemother (2003) 1.04
Distribution of suramin, an antitrypanosomal drug, across the blood-brain and blood-cerebrospinal fluid interfaces in wild-type and P-glycoprotein transporter-deficient mice. Antimicrob Agents Chemother (2007) 0.98
Trypanocidal activity of melamine-based nitroheterocycles. Antimicrob Agents Chemother (2004) 0.95
Studies of genotoxicity and mutagenicity of nitroimidazoles: demystifying this critical relationship with the nitro group. Mem Inst Oswaldo Cruz (2015) 0.75
Isoenzyme analysis of 35 Toxoplasma gondii isolates and the biological and epidemiological implications. J Parasitol (1992) 2.98
Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci (1996) 2.57
Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol (1997) 2.38
A proposal to declare neurocysticercosis an international reportable disease. Bull World Health Organ (2000) 2.11
Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol Lett (1993) 1.72
A controlled trial of the tolerance of amphotericin B infused in dextrose or in Intralipid in patients with haematological malignancies. J Antimicrob Chemother (1994) 1.64
TRPV4 channels mediate the infrared laser-evoked response in sensory neurons. J Neurophysiol (2012) 1.45
L-Arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomiasis. Infect Immun (2000) 1.41
Epilepsy and neurocysticercosis in an Andean community. Int J Epidemiol (1999) 1.38
[Economics of health care in Mali]. Sante (1997) 1.38
Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei. Exp Parasitol (1992) 1.35
Enzymatic reduction studies of nitroheterocycles. Biochem Pharmacol (1999) 1.32
High prevalence of calcified silent neurocysticercosis in a rural village of Mexico. Neuroepidemiology (2003) 1.30
Blood-cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness. J Neurol Sci (2002) 1.22
Prevalence of epilepsy in rural Bolivia: a door-to-door survey. Neurology (1999) 1.21
Review of epidemiological studies searching for a relationship between onchocerciasis and epilepsy. Neuroepidemiology (2004) 1.21
HTLV-I in Burundi (east Africa): lack of reactivity to the HTLV-I immunodominant envelope epitope. J Acquir Immune Defic Syndr (1994) 1.16
Epilepsy in the tropics: II. Clinical presentations, pathophysiology, immunologic diagnosis, economics, and therapy. Epilepsia (1996) 1.15
Acute or subacute alcoholic neuropathy mimicking Guillain-Barré syndrome. J Neurol Sci (1990) 1.13
Headache and cysticercosis in Ecuador, South America. Headache (1995) 1.12
Expression and function of aquaporins in human skin: Is aquaporin-3 just a glycerol transporter? Biochim Biophys Acta (2006) 1.10
Isoenzymic characterization of seven strains of Toxoplasma gondii by isoelectrofocusing in polyacrylamide gels. Am J Trop Med Hyg (1988) 1.08
Estimation of the prevalence of epilepsy in the Benin region of Zinvié using the capture-recapture method. Int J Epidemiol (2000) 1.08
Tick-bite meningoradiculoneuritis: clinical, electrophysiologic, and histologic findings in 10 cases. Neurology (1987) 1.06
Retrograde axonal transport of specific macromolecules as a tool for characterizing nerve terminal membranes. J Neurobiol (1979) 1.06
An epidemiological study of familial neurocysticercosis in an endemic Mexican community. Trans R Soc Trop Med Hyg (2005) 1.04
Pasteurella multocida septicemia and peritonitis in a cirrhotic cock trainer with a pet pig. N Engl J Med (1980) 1.03
Oligodendroglial pathology in canine distemper virus infection in vitro. Acta Neuropathol (1987) 1.03
Influence of asiatic acid, madecassic acid, and asiaticoside on human collagen I synthesis. Planta Med (1994) 1.02
Expression of receptors for enterotoxigenic Escherichia coli during enterocytic differentiation of human polarized intestinal epithelial cells in culture. Infect Immun (1992) 1.02
Antiepileptic therapies in the Mifi Province in Cameroon. Epilepsia (2000) 1.01
Secondary degeneration of oligodendrocytes in canine distemper virus infection in vitro. Lab Invest (1986) 1.01
Low human T cell leukemia virus type II seroprevalence in Africa. J Infect Dis (1994) 1.00
Epilepsy in the tropics: I. Epidemiology, socioeconomic risk factors, and etiology. Epilepsia (1996) 1.00
Parenchymal neurocysticercosis: follow-up and staging by MRI. Neuroradiology (1997) 0.99
[Study of antiglycolipid antibodies in IgM monoclonal dysglobulinemias associated with peripheral neuropathy]. Rev Neurol (Paris) (1988) 0.98
[Cysticercosis and neurocysticercosis: epidemiological survey in North Togo]. Bull Soc Pathol Exot (1990) 0.98
Effect of melarsoprol treatment on circulating IL-10 and TNF-alpha levels in human African trypanosomiasis. Clin Immunol Immunopathol (1997) 0.98
HIV-2 antibodies in African with spastic paraplegia. Lancet (1988) 0.97
Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism. Life Sci (1989) 0.96
Adhering heat-killed human Lactobacillus acidophilus, strain LB, inhibits the process of pathogenicity of diarrhoeagenic bacteria in cultured human intestinal cells. J Diarrhoeal Dis Res (1993) 0.96
Neurocysticercosis: validity of ELISA after storage of whole blood and cerebrospinal fluid on paper. Trop Med Int Health (2001) 0.96
Expression and function of neurotrophins and their receptors in cultured human keratinocytes. J Invest Dermatol (2003) 0.96
Central brain postembryonic development in Drosophila: implication of genes expressed at the interhemispheric junction. J Neurobiol (2000) 0.94
BalI and MspI polymorphisms of the dopamine D3 receptor gene in African Blacks and Caucasians. Hum Hered (1996) 0.94
Central motor conduction in motor neuron disease. Ann Neurol (1987) 0.94
Canine distemper virus does not infect oligodendrocytes in vitro. J Neurol Sci (1985) 0.92
Effect of megazol on Trypanosoma brucei brucei acute and subacute infections in Swiss mice. Acta Trop (1995) 0.91
Trypanosoma brucei brucei: a long-term model of human African trypanosomiasis in mice, meningo-encephalitis, astrocytosis, and neurological disorders. Exp Parasitol (1997) 0.91
Inducible nitric oxide synthase and nitrotyrosine in the central nervous system of mice chronically infected with Trypanosoma brucei brucei. Exp Parasitol (2000) 0.90
A monoclonal antibody that binds to both astrocytes and myelin sheaths. J Neuroimmunol (1985) 0.90
Parkinson's disease and environmental factors. Matched case-control study in the Limousin region, France. Neuroepidemiology (2000) 0.90
Treatment of human African trypanosomiasis. Bull World Health Organ (2003) 0.89
Epidemiological study of neuro-cysticercosis in northern Togo (West Africa). Acta Leiden (1989) 0.89
[The hospital-borne tetanus in the reference service of the Donka National Hospital in Conakry (2001-2011)]. Bull Soc Pathol Exot (2013) 0.89
Assessment of linear measurements of bone for implant sites in the presence of metallic artefacts using cone beam computed tomography and multislice computed tomography. Int J Oral Maxillofac Surg (2011) 0.89
Onchocerciasis and epilepsy: a matched case-control study in the Central African Republic. Am J Epidemiol (1999) 0.89
Harbouring in the brain: A focus on immune evasion mechanisms and their deleterious effects in malaria and human African trypanosomiasis. Int J Parasitol (2006) 0.88
Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors. Lancet (1993) 0.88
Seroprevalence of cysticercosis in Bénin. Trans R Soc Trop Med Hyg (1999) 0.88
Human macrophage tumor necrosis factor (TNF)-alpha production induced by Trypanosoma brucei gambiense and the role of TNF-alpha in parasite control. J Infect Dis (2001) 0.88
The duality of sleeping sickness: focusing on sleep. Sleep Med Rev (2001) 0.88
Changes in human fasciolosis in a temperate area: about some observations over a 28-year period in central France. Parasitol Res (2000) 0.88
Specific antibody activity against neuroendocrine tissue in a case of POEMS syndrome with IgG gammopathy. Neurology (1988) 0.87
[Subacute sclerosing panencephalitis: electroencephalographic study (9 cases)]. Bull Soc Med Afr Noire Lang Fr (1970) 0.87
Sleep-wake cycle in human African trypanosomiasis. J Clin Neurophysiol (1993) 0.87
Uptake of the nitroimidazole drug megazol by African trypanosomes. Biochem Pharmacol (2000) 0.87
Entomological survey and report of a knockdown resistance mutation in the malaria vector Anopheles gambiae from the Republic of Guinea. Trans R Soc Trop Med Hyg (2010) 0.87
Human epidermal cells progressively lose their cardiolipins during ageing without change in mitochondrial transmembrane potential. Mech Ageing Dev (1994) 0.87
Dietary antioxidants, peroxidation and cardiovascular risks. J Nutr Health Aging (2002) 0.86
Detection and characterization of autoantibodies directed against neurofilament proteins in human African trypanosomiasis. Am J Trop Med Hyg (1997) 0.86
Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors. Neuroepidemiology (1996) 0.86
Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitioner-based survey and a pharmacy-based survey in France. Pharmacoepidemiol Drug Saf (2001) 0.86
N-Hexane- and methylethylketone-induced polyneuropathy. Abnormal accumulation of glycogen in unmyelinated axons. Report of a case. Acta Neuropathol (1981) 0.86
Clinical follow-up in the rat experimental model of African trypanosomiasis. Exp Biol Med (Maywood) (2003) 0.85
[Epilepsy and its impact in northwest region of the Central African Republic]. Med Trop (Mars) (1997) 0.85
Multicenter phase II trial of interleukin-2, interferon-alpha, and 13-cis-retinoic acid in patients with metastatic renal-cell carcinoma. J Clin Oncol (1998) 0.85
Urinary beta 2-microglobulin: early indicator of high dose cisdiamminedichloroplatinum nephrotoxicity? Influence of furosemide. Cancer Chemother Pharmacol (1986) 0.85
Hypoxic pulmonary vasoconstriction. Gen Pharmacol (1999) 0.84
[Toxoplasma gondii: ultrastructural study of cystic formations observed in human fibroblast culture]. Ann Parasitol Hum Comp (1989) 0.84
[Human African trypanosomiasis]. C R Seances Soc Biol Fil (1996) 0.84
Risk factors for surgical site infection in children at the teaching hospital Gabriel Touré, Bamako. J Hosp Infect (2011) 0.84
Role of potassium channels and nitric oxide in the relaxant effects elicited by beta-adrenoceptor agonists on hypoxic vasoconstriction in the isolated perfused lung of the rat. Br J Pharmacol (1999) 0.84
[An efficacy trial on Trypanosoma brucei brucei of molecules permeating the blood-brain barrier and of megazol]. Bull Soc Pathol Exot (1994) 0.83
Disruption of endocrine rhythms in sleeping sickness with preserved relationship between hormonal pulsatility and the REM-NREM sleep cycles. J Biol Rhythms (1996) 0.83
Cross-reactivity of anti-galactocerebroside autoantibodies with a Trypanosoma brucei proteolipidic epitope. Clin Exp Immunol (2000) 0.83